|
State of California-Health and Welfare Agency Department of Health Services
<br /> Page 3 of_9 pages
<br /> RADIOACTIVE MATERIAL LICENSE License Number. 1276-39
<br /> Supp mntary Sheet Amendment Number:�$
<br /> LICENSE CONDITIONS
<br /> 10. Radioactive material shall be used only at the following location:
<br /> (a) 1800 North California Street, Stockton, California
<br /> 11. This license is subject to an annual fee for sources of radioactive material authorized to be possessed at anyone
<br /> time as specified in items 6, 7, 8 and 9 of this license. The annual fee for this license is required by and
<br /> computed in accordancewith Title 17,California Code of Regulations,Sections 30230-30232 and is also subject
<br /> to an annual cost-of-living adjustment pursuant to Section 100425 of the California Health and Safety Code.
<br /> 12. The individuals named below are authorized the specific uses of radioactive material described in Items 6, 7,
<br /> 8 and 9 of this license as follows:
<br /> (a) J. David Bernard, MD. Groups 1, 2, 3, 4, 5 and 9
<br /> (b) Laszlo B. Fodor, MD. Groups 1, 2, 3, 4 (I-131 only), 5 and 9
<br /> (c) Daniel W. Terry, MD. Groups 1, 2, 3, 4 (I-131 only), 5 and 9
<br /> (d) Jack L. Funamura, MD. Groups 1, 2, 3, 4 (I-131 only), 5 and 9
<br /> (e) M Lousie Del Paine, MD. Groups 1, 2, 3, and 9
<br /> (f) Masanobu Kamigaki, MD. Groups 1, 2, 3, and 9
<br /> (g) Lynett Hart, MD. Group 6
<br /> (h) Henry Y. T. Wong, MD. Groups 4 (P-32 and Sr-89 only) and 6
<br /> (i) Edward C. Greenleaf, MD. Groups 4 (Strontium 89 only), 6 and 9
<br /> 0) Royce J. Biddle, MD. Groups 1, 2, 3 and 9
<br /> (k) James D. Rooke, MD. Groups 4 (thyroid therapy only) and 5
<br /> (1) Frank S. Callcott, MD. Groups 1, 2, 3, 4, 5 and 9
<br /> (m) William N. Gonser, MD. Groups 1, 2, 3 and 9
<br /> (n) Ramesh N. Dhamwat, MD. Groups 2 (Cardiac studies only) and 9
<br /> (o) Thomas M Bey, MD. Groups 1, 2, 3, and 9
<br /> 13. Except as specifically provided otherwise by this license,the licensee shall possess and use radioactive material
<br /> described in Items 6, 7, 8 and 9 of this license in accordance with statements,representations, and procedures
<br /> contained in the documents listed below. The Department's regulations shall govern unless the statements,
<br /> representations, and procedures in the licensee's application and correspondence are more restrictive than the
<br /> regulations.
<br /> (a) The application with attachments dated September 28, 1987, signed by Jack L. Funamura, MD.
<br /> (b) The letter with attachments dated October 6, 1988, signed by Lawrence A. Philipp.
<br /> (c) The letter with attachments dated November 18, 1988, signed by Jack L. Funamura, MD.
<br /> (d) The letter dated February 21, 1989, and the letter with attachments dated February 22, 1989, both signed
<br /> by Jack L. Funamura, MD.
<br /> (e) The letters dated April 19, 1989 and May 18, 1989, both signed by Richard AL Seidler, Vice President.
<br />
|